The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.80
Bid: 38.80
Ask: 39.55
Change: 0.40 (1.04%)
Spread: 0.75 (1.933%)
Open: 38.65
High: 38.80
Low: 38.65
Prev. Close: 38.40
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral

Mon, 22nd Mar 2021 09:41

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

UBS RAISES RIGHTMOVE TO 'BUY' ('NEUTRAL') - TARGET 645 (630) PENCE

----------

DEUTSCHE BANK RAISES PRUDENTIAL PRICE TARGET TO 1,700 (1,400) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS IAG TO 'HOLD' ('BUY') - PRICE TARGET 220 PENCE

----------

BERNSTEIN RAISES BURBERRY PRICE TARGET TO 2,098 (1,730) PENCE - 'MARKET-PERFORM'

----------

BERENBERG RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 800 (740) PENCE - 'HOLD'

----------

CITIGROUP RAISES BURBERRY PRICE TARGET TO 2,200 (1,900) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES LLOYDS BANKING TO 'OVERWEIGHT' (NEUTRAL) - PRICE TARGET 51 (42) PENCE

----------

JPMORGAN RAISES NATWEST PRICE TARGET TO 210 (190) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BARCLAYS PRICE TARGET TO 210 (190) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS ENTAIN PRICE TARGET TO 1,628 (1,644) PENCE - 'NEUTRAL'

----------

RBC RAISES ANTOFAGASTA PRICE TARGET TO 1,400 (1,150) PENCE - 'UNDERPERFORM'

----------

RBC RAISES GLENCORE PRICE TARGET TO 370 (310) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANGLO AMERICAN PRICE TARGET TO 4,100 (3,700) PENCE - 'OUTPERFORM'

----------

RBC RAISES RIO TINTO PRICE TARGET TO 6,500 (6,000) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES BHP GROUP PRICE TARGET TO 2,700 (2,500) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES ROLLS-ROYCE PRICE TARGET TO 169 (107) PENCE - 'BUY'

----------

RBC RAISES AVIVA PRICE TARGET TO 450 (410) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

UBS RAISES COMPUTACENTER TO 'NEUTRAL' ('SELL') - TARGET 2,375 (21,35) PENCE

----------

LIBERUM RAISES JD WETHERSPOON PRICE TARGET TO 1,400 (1,150) PENCE - 'HOLD'

----------

LIBERUM RAISES NATIONAL EXPRESS PRICE TARGET TO 385 (275) PENCE - 'BUY'

----------

CITIGROUP RAISES SOFTCAT TO 'NEUTRAL' ('SELL') - TARGET 1,600 (1,200) PENCE

----------

JEFFERIES RAISES TULLOW OIL PRICE TARGET TO 21 (13) PENCE - 'UNDERPERFORM'

----------

BERNSTEIN RAISES WIZZ AIR PRICE TARGET TO 6,750 (5,500) PENCE - 'OUTPERFORM'

----------

BERNSTEIN RAISES EASYJET PRICE TARGET TO 1,150 (1,000) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES CLS HOLDINGS PRICE TARGET TO 300 (275) PENCE - 'BUY'

----------

BERENBERG CUTS HOMESERVE PRICE TARGET TO 1,380 (1,400) PENCE - 'BUY'

----------

JPMORGAN CUTS VIRGIN MONEY TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 180 (130) PENCE

----------

RBC RAISES TRAVIS PERKINS TO 'OUTPERFORM' ('SECTOR PERFORM') TARGET 2,000 (1,300) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

BERNSTEIN RAISES RYANAIR PRICE TARGET TO 18.50 (17.50) EUR - 'OUTPERFORM'

----------

RBC CUTS CENTRAL ASIA METALS TO 'SECTOR PERFORM' ('OUTPERFORM') - 310 PENCE

----------

LIBERUM RAISES FUTURA MEDICAL PRICE TARGET TO 68 (55) PENCE - 'BUY' (on Friday)

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Apr 2022 18:03

TRADING UPDATES: Billington faces headwinds; Immotion plans spin-off

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
23 Mar 2022 15:35

Futura signs up Korean partner for erection gel product

(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.

Read more
23 Mar 2022 11:50

Futura Medical shares rise on licensing deal with Menarini Korea

(Alliance News) - Futura Medical PLC shares jumped on Wednesday after the company said it has entered a licensing agreement with A Menarini Korea Ltd or the exclusive rights to commercialise its MED3000 treatment in South Korea.

Read more
20 Dec 2021 21:59

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

TRADING UPDATES: Silver Bullet faces cyber attack; Zoltav to delist

Read more
20 Dec 2021 10:46

Futura Medical makes good progress with topical erection gel treatment

(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.

Read more
29 Oct 2021 15:57

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Read more
8 Oct 2021 13:51

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

EXECUTIVE CHANGES: WH Ireland hires new CFO; Grubhub founder exits JET

Read more
29 Sep 2021 13:22

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens

Read more
27 Sep 2021 16:54

Futura Medical inks licensing deal with Labtec Pharma

(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.

Read more
27 Sep 2021 12:01

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

IN BRIEF: Futura Medical teams with Labatec to commercialise MED3000

Read more
22 Sep 2021 17:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
15 Sep 2021 20:23

IN BRIEF: Futura progressing US regulatory submission for MED3000

IN BRIEF: Futura progressing US regulatory submission for MED3000

Read more
1 Sep 2021 20:56

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

Read more
31 Aug 2021 15:08

Futura enters erection gel licensing deal with M8

(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.

Read more
19 Jul 2021 19:13

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.